Episode 236 - Dan O’Connell - President & CEO of Acumen Pharmaceuticals

<p>In this episode of <strong>The BioHub by Avetix</strong>, I’m joined by <strong>Dan O’Connell</strong>, President and CEO of <strong>Acumen Pharmaceuticals</strong>.</p><p><br /></p><p>Dan shares his journey from neuroscience investing and company creation into the CEO role, and how he has helped take Acumen from a private, preclinical biotech into a publicly traded clinical-stage company focused on Alzheimer’s disease.</p><p><br /></p><p>We discuss the origins of Acumen, what it was like taking the company public with just nine people, navigating a difficult few years for biotech, balancing financial discipline with clinical progress, and the major readout ahead later this year.</p><p> </p>